Evaluation of a new commercial automated planning software for tangential breast intensity-modulated radiation therapy

Abstract

Automated treatment planning may decrease the effort required in planning and promote increased routine clinical use of intensity-modulated radiation therapy (IMRT) for many breast cancer patients. The aim of this study was to evaluate a new commercial automated planning software for tangential breast IMRT by comparing it with clinical plans from whole-breast irradiation. We prospectively enrolled 150 patients with Stage 0–1 breast cancer who underwent breast-conserving surgery at our institution between September 2016 and August 2017. Total doses of 42.56\xa0Gy in 16 fractions (n\u2009=\u200998) or 50\xa0Gy in 25 fractions (n\u2009=\u200944) were used. All treatment plans were retrospectively re-planned using the automated breast planning (ABP) software. All automated plans generated clinically deliverable beam parameters with no patient body collision and no contralateral breast pass through. The mean homogeneity index of the automatically generated clinical target volume, percentage volume of lungs receiving dose more than 20\xa0Gy, mean heart dose, and dose to the highest irradiated 2-cc volumes of the irradiated volume were 0.077\u2009±\u20090.019, 4.2%\u2009±\u20091.2%, 142\u2009±\u200969\xa0cGy, and 105.8%\u2009±\u20091.7% (prescribed dose: 100%), respectively. The mean planning time was 4.8\u2009±\u20091.4\xa0min. The ABP software demonstrated high clinical acceptability and treatment planning cost efficiency for tangential breast IMRT. The ABP software may be useful for delivering high-quality treatment to a majority of patients with early-stage breast cancer.